These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1247 related items for PubMed ID: 18800143
1. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study). Erdine S, Ro YM, Tse HF, Howes LG, Aguilar-Salinas CA, Chaves H, Guindy R, Chopra P, Moller RA, Schou IM, Gemini-AALA Investigators. J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143 [Abstract] [Full Text] [Related]
2. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme. Richard Hobbs FD, Gensini G, John Mancini GB, Manolis AJ, Bauer B, Genest J, Feldman RD, Harvey P, Jenssen TG, da Silva PM, JEWEL Study Group. Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):472-80. PubMed ID: 19407658 [Abstract] [Full Text] [Related]
3. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program). Hobbs FD, Gensini G, Mancini GB, Manolis AJ, Bauer B, Böhler S, Genest J, Feldman R, Harvey P, Jenssen TG, Metcalfe M, da Silva PM, JEWEL Study Group. Int J Cardiol; 2006 Jun 16; 110(2):242-50. PubMed ID: 16338012 [Abstract] [Full Text] [Related]
4. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial. Preston RA, Harvey P, Herfert O, Dykstra G, Jukema JW, Sun F, Gillen D. J Clin Pharmacol; 2007 Dec 16; 47(12):1555-69. PubMed ID: 18048574 [Abstract] [Full Text] [Related]
5. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group. Clin Ther; 2004 Nov 16; 26(11):1821-33. PubMed ID: 15639694 [Abstract] [Full Text] [Related]
13. Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy. Cowie MR. Int J Clin Pract; 2005 Jul 15; 59(7):839-46. PubMed ID: 15963213 [Abstract] [Full Text] [Related]
16. Post hoc analysis of the Cluster Randomized Usual Care versus Caduet Investigation Assessing Long-term risk (CRUCIAL) trial. Hradec J, Zamorano J, Sutradhar S. Curr Med Res Opin; 2013 Jun 15; 29(6):589-96. PubMed ID: 23464930 [Abstract] [Full Text] [Related]
19. Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia. Jones PH, McKenney JM, Karalis DG, Downey J. Am Heart J; 2005 Jan 15; 149(1):e1. PubMed ID: 15660024 [Abstract] [Full Text] [Related]